Prediction of radiation pneumonitis in lung cancer patients: a systematic review
Journal of Cancer Research & Clinical Oncology, 08/08/2012
Evidence Based Medicine
Zhang XJ et al. – Following factors were identified significant for radiation pneumonitis (RP), including tumor located not in the upper lobe, smokers, combined with chronic lung diseases or diabetes mellitus, low pre–radiation therapy (RT) pulmonary function, RCT, RT/RT combined with chemotherapy (RCT) without amifostine and plasma end/pre–RT TGF–β1 ratio ≥1. Dose–volume parameters included the average of mean lung dose (MLD) of disease lung, GTV and V 5, V 10, V 20, V 30 of bilateral lung.



